Impact of cardiovascular health and genetic risk on coronary artery disease in Chinese adults
暂无分享,去创建一个
Hongbing Shen | Fangchao Liu | Jianxin Li | Xiao-qing Liu | Jie Cao | Lin Yu | F. Lu | Xian-ping Wu | Liancheng Zhao | Ying Li | Jianfeng Huang | Xiangfeng Lu | Shufeng Chen | Hongxia Ma | X. Mo | D. Hu | Keyong Huang | D. Gu | Xiaoge Niu | Yingxin Zhao | Zhongying Liu | Qingmei Cui | C. Shen | Huan-Ling Zhang | Laiyuan Wang | Zhibin Hu | Dongfeng Gu
[1] W. Rosamond,et al. Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association , 2022, Circulation.
[2] E. Boerwinkle,et al. American Heart Association’s Life’s Simple 7: Lifestyle Recommendations, Polygenic Risk, and Lifetime Risk of Coronary Heart Disease , 2022, Circulation.
[3] OUP accepted manuscript , 2022, European Heart Journal.
[4] OUP accepted manuscript , 2022, European Heart Journal.
[5] Sathish Kumar Jayapal,et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 , 2020, Journal of the American College of Cardiology.
[6] A. Khera,et al. Genome-Wide Polygenic Score, Clinical Risk Factors, and Long-Term Trajectories of Coronary Artery Disease , 2020, Arteriosclerosis, thrombosis, and vascular biology.
[7] Marc S. Williams,et al. Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups. , 2020, American journal of human genetics.
[8] Benjamin Neale,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults Implications for Primary Prevention , 2019 .
[9] Deepak L. Bhatt,et al. Heart Failure Risk Stratification and Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Type 2 Diabetes Mellitus. , 2019, Circulation.
[10] E. Zeggini,et al. Genomics of disease risk in globally diverse populations , 2019, Nature Reviews Genetics.
[11] A. Khera,et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Journal of the American College of Cardiology.
[12] Helen E. Parkinson,et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..
[13] Shu Ye,et al. Genomic Risk Prediction of Coronary Artery Disease in 480,000 Adults , 2018, Journal of the American College of Cardiology.
[14] Pim van der Harst,et al. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study , 2018, JAMA cardiology.
[15] J. Erdmann,et al. A decade of genome-wide association studies for coronary artery disease: the challenges ahead , 2018, Cardiovascular research.
[16] Zuo Chen,et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012–2015 , 2018, Circulation.
[17] Xueli Yang,et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project , 2018, Science China Life Sciences.
[18] P. Elliott,et al. Genetic Predisposition to High Blood Pressure and Lifestyle Factors: Associations With Midlife Blood Pressure Levels and Cardiovascular Events , 2017, Circulation.
[19] A. Khera,et al. Genetics of coronary artery disease: discovery, biology and clinical translation , 2017, Nature Reviews Genetics.
[20] E. Boerwinkle,et al. Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease. , 2016, The New England journal of medicine.
[21] Xueli Yang,et al. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China) , 2016, Circulation.
[22] C. Labos,et al. Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary Syndromes , 2016, Arteriosclerosis, thrombosis, and vascular biology.
[23] Jun Liu,et al. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi–Provincial Cohort Study , 2015, European journal of preventive cardiology.
[24] P. Andersen,et al. Decomposition of number of life years lost according to causes of death , 2013, Statistics in medicine.
[25] R. Sacco,et al. Ideal Cardiovascular Health Predicts Lower Risks of Myocardial Infarction, Stroke, and Vascular Death Across Whites, Blacks, and Hispanics: The Northern Manhattan Study , 2012, Circulation.
[26] D. Srivastava,et al. Genetics of Human Cardiovascular Disease , 2012, Cell.
[27] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[28] D. Spiegelman,et al. Point and interval estimates of partial population attributable risks in cohort studies: examples and software , 2007, Cancer Causes & Control.
[29] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.
[30] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .